Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI)
- 11 September 2020
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 99 (1), 41-48
- https://doi.org/10.1159/000510098
Abstract
Objectives: To assess the individual treatment strategies among international experts in peritoneal carcinosis, specifically their decision-making in the process of patient selection for hyperthermic intraperitoneal chemotherapy (HIPEC) in women suffering from ovarian cancer, to identify relevant decision-making criteria, and to quantify the level of consensus for or against HIPEC. Methods: The members of the executive committee of the Peritoneal Surface Oncology Group International (PSOGI) were asked to describe the clinical conditions under which they would recommend HIPEC in patients with ovarian cancer and to describe any disease or patient characteristics relevant to their decision. All answers were then merged and converted into decision trees. The decision trees were then analyzed by applying the objective consensus methodology. Results: Nine experts in surgical oncology provided information on their multidisciplinary treatment strategy including HIPEC for patients with advanced ovarian cancer. Three of the total of 12 experts did not perform HIPEC. Five criteria relevant to the decision on whether HIPEC is performed were applied. In patients with resectable disease, a peritoneal cancer index (PCI) Discussion and Conclusion: Among surgical oncology experts in peritoneal surface malignancy and HIPEC, HIPEC plays an important role in primary and recurrent ovarian cancer, and the PCI is the most important criterion in this decision.Keywords
This publication has 30 references indexed in Scilit:
- Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerJournal of Clinical Oncology, 2015
- Staging Classification for Cancer of the Ovary, Fallopian Tube, and PeritoneumObstetrics & Gynecology, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Objective consensus from decision treesRadiation Oncology, 2014
- Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancerJournal of Visceral Surgery, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Swarm-Based MedicineJournal of Medical Internet Research, 2013
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian CancerThe New England Journal of Medicine, 2010
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trialsCancer, 2009
- Peritonectomy ProceduresAnnals of Surgery, 1995